Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

Name: Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Published: 1998
License: Public Domain

Eli Lilly and Company · 1998

ClinicalTrials.gov · Datasets · License: Public Domain · 1998

Open Source ↗

carcinoma monoclonal-antibody vaccine

carcinoma, small cell lung, ld small cell lung cancer, bec2, vaccine, adjuvant, monoclonal antibody, ld small cell lung cancer (va classification, zelen, 1973), interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

Related documents